Frontlight ResearchEarly access
Trial site
Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud
- 11running trials
- 6closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Colorectal cancer2 trials
- Kidney cancer2 trials
- Lung cancer2 trials
- Myeloproliferative neoplasms2 trials
- Obesity2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Brain metastases1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Melanoma1 trial
- and 5 more
- Phase
- Phase 311 trials
- Phase 23 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed3 trials
- Terminated3 trials
- Not yet recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Incyte Corporation5 trials
- Eli Lilly and Company3 trials
- Amgen2 trials
- AstraZeneca1 trial
- Centre Antoine Lacassagne1 trial
- and 5 more
Running trials
Not yet recruiting
Active, not recruiting
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Terminated
Terminated
Terminated
Completed
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Site data: ClinicalTrials.govUpdated 12 Nov 2026